Akemi Inagaki

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy

Tetsuhiko Sato, Akemi Inagaki, Kazuharu Uchida et al. · Transplantation · 2003 · 60 citations

Medicine, Endocrinology, Nephrology +17

Aromatase Excess Syndrome: Identification of Cryptic Duplications and Deletions Leading to Gain of Function of<i>CYP19A1</i>and Assessment of Phenotypic Determinants

Maki Fukami, Makio Shozu, Shun Soneda et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 36 citations

Life Sciences, Genetics, Molecular Genetics +17

Age-associated decrease in response of rat aquaporin-2 gene expression to dehydration

Y. Terashima, Kunïkazu Kondo, Akemi Inagaki et al. · Life Sciences · 1998 · 20 citations

Life Sciences, Molecular Biology, Physiology +14